Lowering HbA1c in type 2 diabetics results in reduced risk of coronary heart disease and all-cause mortality
Abstract
Aims
To assess to which extent lowering the level of HbA1c influences the 10-year risk of coronary heart disease (CHD) and all-cause mortality in patients with type 2 diabetes mellitus.
Methods
A literature search in Pubmed and Embase was performed, and the absolute risks in the results of the relevant and valid studies compared.
Results
Each study shows that with a decreasing percentage of HbA1c, both the risk of developing CHD and the risk of mortality decrease.
Conclusions
Lowering HbA1c in type 2 diabetics decreases the absolute risk of developing CHD by 5–17%, as well as decreasing all-cause mortality by 6–15%.
Keywords: Diabetes mellitus type 2, HbA1c, Coronary heart disease, Mortality
To access this article, please choose from the options below
PII: S1751-9918(07)00184-2
doi:10.1016/j.pcd.2007.12.004
© 2008 Primary Care Diabetes Europe. Published by Elsevier Inc. All rights reserved.
